Feed / IONS

Ionis Pharmaceuticals, Inc.

IONS

Healthcare · 59.74 +1.8% today

Participation confirmed · construction unavailableMarket checked 21 Aug, 15:55 GMT-4

Jodie situation report

Ionis Pharmaceuticals, Inc.'s move is being confirmed by its market group.

No new filing conclusion is available. 8 of 13 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 10 directly disclosed connections are confirming.

Company+1.8% todayVolume comparison unavailable
Market group8 of 13 activeBiotechnology Therapeutics · building
Disclosed network0 of 8 confirmingNo filing-linked name is confirming now
What would change this read
  • At least 9 of 13 members remain active in the next snapshot.
  • Capital-flow agreement rises above 55%.
  • A filing-linked outsider such as BMRN begins moving with the group.

Invalidation: The live read weakens if participation falls to 4 of 13 members or fewer.

Watch this read

Who this business touches

The relationships behind IONS

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

AZNAstraZeneca PLCpartnerApr 29, 2026

WAINUA (Eplontersen) Collaboration with AstraZeneca Our financial results for the three months ended March 31, 2026 and 2025 reflected the cost-sharing provisions related to our collaboration with AstraZeneca to develop and commercialize WAINUA for the treatm…

BIIBBiogen Inc.partnerApr 29, 2026

Biogen Marketed Medicines SPINRAZA In 2012, we entered into a collaboration agreement with Biogen to develop and commercialize SPINRAZA.

Depended on by

SRPTSarepta Therapeutics, Inc.competitorMar 2, 2026

In addition, while Wave announced its intention to discontinue development of suvodirsen and suspend development of WVE-N531, it is conducting clinical trials for its exon 53 oligonucleotide, WVE-N531.

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 9 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

IONS is currently a Participant in the organic co-movement group Biotechnology Therapeutics. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.